These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

869 related articles for article (PubMed ID: 28521640)

  • 21. Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.
    Ruan P; Xu SY; Zhou BP; Huang J; Gong ZJ
    J Int Med Res; 2013 Oct; 41(5):1732-9. PubMed ID: 23908397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay.
    Chung KH; Kim W; Kim BG; Lee HY; Jin E; Cho Y; Seo JY; Kim HY; Jung YJ; Kim JW; Jeong JB; Lee KL
    Gut Liver; 2015 Sep; 9(5):657-64. PubMed ID: 25717049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
    Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
    Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
    Petit MA; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C
    Arch Virol Suppl; 1992; 4():105-12. PubMed ID: 1280500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Single Dose of Anti-HBsAg Antibody-Encoding mRNA-LNPs Suppressed HBsAg Expression: a Potential Cure of Chronic Hepatitis B Virus Infection.
    Chen B; Chen Y; Li J; Wang C; Song W; Wen Y; Lin J; Wu Y; Ying T
    mBio; 2022 Aug; 13(4):e0161222. PubMed ID: 35862767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells.
    Neumann AU; Phillips S; Levine I; Ijaz S; Dahari H; Eren R; Dagan S; Naoumov NV
    Hepatology; 2010 Sep; 52(3):875-85. PubMed ID: 20593455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
    Bayliss J; Yuen L; Rosenberg G; Wong D; Littlejohn M; Jackson K; Gaggar A; Kitrinos KM; Subramanian GM; Marcellin P; Buti M; Janssen HLA; Gane E; Sozzi V; Colledge D; Hammond R; Edwards R; Locarnini S; Thompson A; Revill PA
    Gut; 2017 Nov; 66(11):2013-2023. PubMed ID: 27534671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.
    Kefalakes H; Jochum C; Hilgard G; Kahraman A; Bohrer AM; El Hindy N; Heinemann FM; Verheyen J; Gerken G; Roggendorf M; Timm J
    J Hepatol; 2015 Jul; 63(1):13-9. PubMed ID: 25646888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B surface antigen monitoring and management of chronic hepatitis B.
    Sonneveld MJ; Zoutendijk R; Janssen HL
    J Viral Hepat; 2011 Jul; 18(7):449-57. PubMed ID: 21692954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection.
    Golsaz Shirazi F; Mohammadi H; Amiri MM; Singethan K; Xia Y; Bayat AA; Bahadori M; Rabbani H; Jeddi-Tehrani M; Protzer U; Shokri F
    J Gastroenterol Hepatol; 2014 May; 29(5):1083-91. PubMed ID: 24325676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection.
    Tsuge M; Hiraga N; Uchida T; Kan H; Miyaki E; Masaki K; Ono A; Nakahara T; Abe-Chayama H; Zhang Y; Naswa MG; Kawaoka T; Miki D; Imamura M; Kawakami Y; Aikata H; Ochi H; Hayes CN; Chayama K
    J Gastroenterol; 2016 Nov; 51(11):1073-1080. PubMed ID: 26943168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection.
    Fumagalli V; Di Lucia P; Venzin V; Bono EB; Jordan R; Frey CR; Delaney W; Chisari FV; Guidotti LG; Iannacone M
    J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32761167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients.
    Boyd A; Canini L; Gozlan J; Lascoux-Combe C; Miailhes P; Fonquernie L; Girard PM; Lacombe K
    J Clin Virol; 2017 Oct; 95():55-60. PubMed ID: 28869890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
    Yuan Q; Song LW; Cavallone D; Moriconi F; Cherubini B; Colombatto P; Oliveri F; Coco BA; Ricco G; Bonino F; Shih JW; Xia NS; Brunetto MR
    PLoS One; 2015; 10(6):e0130209. PubMed ID: 26115521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in therapeutics for chronic hepatitis B.
    Yang N; Bertoletti A
    Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wild-type and 'a' epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody.
    Mesenas SJ; Chow WC; Zhao Y; Lim GK; Oon CJ; Ng HS
    J Gastroenterol Hepatol; 2002 Feb; 17(2):148-52. PubMed ID: 11966944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
    Fung J; Lai CL; Yuen MF
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.